Irene Tong serves as the CEO of Longwood Capital LLP, a prominent investment firm specializing in the healthcare sector, blockchain technology, artificial intelligence, and financial services. With a robust background in biotechnology and biopharma, Irene has honed her expertise in identifying and nurturing innovative healthcare...
Irene Tong serves as the CEO of Longwood Capital LLP, a prominent investment firm specializing in the healthcare sector, blockchain technology, artificial intelligence, and financial services. With a robust background in biotechnology and biopharma, Irene has honed her expertise in identifying and nurturing innovative healthcare companies across all equity stages, from seed funding to pre-IPO investments. Her strategic vision is particularly focused on cutting-edge areas such as RNA therapeutics, HIV drug development, vaccination strategies, CAR-T therapies, immuno-oncology, CRISPR technology, and small molecule inhibitors, as well as advancements in cancer early detection.
Under Irene's leadership, Longwood Capital has successfully executed a range of key projects, including high-stakes mergers and acquisitions, licensing agreements, and strategic investments aimed at bolstering Chinese portfolios while facilitating listings on major exchanges like NASDAQ, HKEX, and the Shanghai/Shenzhen stock markets. Her commitment to leveraging pioneering technologies and innovative business models has positioned Longwood Capital as a leader in delivering high returns on investment in the rapidly evolving healthcare landscape.
Irene's extensive experience, which includes training at the Dana-Farber Cancer Institute (DFCI), equips her with a unique perspective on the complexities of the biotech industry. Her skills in growth strategy, management consulting, and quantitative analysis enable her to guide Longwood Capital in making informed investment decisions that align with market trends and emerging technologies. As a thought leader in the investment community, Irene Tong continues to drive Longwood Capital's mission of fostering transformative healthcare solutions that have the potential to improve patient outcomes globally.
